Banco Bilbao Vizcaya Argentaria S.A. Boosts Holdings in Corteva, Inc. $CTVA

Banco Bilbao Vizcaya Argentaria S.A. grew its stake in Corteva, Inc. (NYSE:CTVA) by 135.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 204,006 shares of the company’s stock after purchasing an additional 117,194 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in Corteva were worth $13,796,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of CTVA. Activest Wealth Management boosted its holdings in Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after buying an additional 200 shares during the last quarter. True Wealth Design LLC raised its holdings in shares of Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after acquiring an additional 264 shares during the last quarter. Total Investment Management Inc. purchased a new position in shares of Corteva in the second quarter valued at approximately $27,000. Twin Peaks Wealth Advisors LLC purchased a new position in shares of Corteva in the second quarter valued at approximately $29,000. Finally, Redmont Wealth Advisors LLC acquired a new stake in shares of Corteva in the third quarter worth approximately $29,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on CTVA shares. Wells Fargo & Company boosted their price target on Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Royal Bank Of Canada lifted their target price on shares of Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $88.00 target price on shares of Corteva in a report on Thursday, February 5th. Oppenheimer set a $86.00 target price on shares of Corteva in a research report on Thursday, February 5th. Finally, Bank of America raised their price target on shares of Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Thursday, January 8th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $82.90.

Corteva Stock Performance

Shares of Corteva stock opened at $79.13 on Monday. The business’s 50 day moving average price is $74.11 and its 200 day moving average price is $69.17. The company has a market cap of $53.22 billion, a price-to-earnings ratio of 50.08, a PEG ratio of 2.71 and a beta of 0.72. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. Corteva, Inc. has a one year low of $53.40 and a one year high of $80.90.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. During the same period in the prior year, the business earned $0.32 EPS. The firm’s quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is presently 45.57%.

Insider Transactions at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.15% of the company’s stock.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.